Completed
Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 Diabetes
NCT01456130
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Fukuoka, Japan
- Kurume-shi, Fukuoka, Japan
- Sapporo, Hokkaido, Japan